Prior to becoming chairman and CEO of Spectrum, Dr. Shrotriya was the Worldwide Executive Director for CNS (central nervous system) Clinical Research at Bristol Myers-Squibb (BMY), where he worked for 18 years.
FORBES: Straightforward Talk From Spectrum Pharmaceuticals Helps Attract Investors